Cite
HARVARD Citation
Pawaskar, D. et al. (2022). Pharmacokinetic/pharmacodynamic modeling for dose selection for the first‐in‐human trial of the activated Factor XII inhibitor garadacimab (CSL312). Clinical and translational science. 15 (3), pp. 709-720. [Online].